There are two types of anticoagulants. The ones listed previously in the thread are newer types, however previously and currently the mainstay of these drugs was Warfarin, originally a poison for killing rats by preventing their blood from clotting.
Warfarin does a great job but requires the patient to be monitored fairly closely during treatment, which is expensive in terms of manpower. The newer ones can just be dished out for people to take as instructed. The new contract could just be a reflection of NHS moving away from Warfarin.
I would love to know if this was outside of the ‘normal’ contract size for anticoagulants.
There are two types of anticoagulants. The ones listed previously in the thread are newer types, however previously and currently the mainstay of these drugs was Warfarin, originally a poison for killing rats by preventing their blood from clotting.
Warfarin does a great job but requires the patient to be monitored fairly closely during treatment, which is expensive in terms of manpower. The newer ones can just be dished out for people to take as instructed. The new contract could just be a reflection of NHS moving away from Warfarin.
Thank you for your reply, it’s always nice to get a different perspective on these things.